Antisense oligonucleotides
Drug / Medication
A very exciting new class of drugs currently in development, designed to specifically lower Lp(a) levels by targeting the Lp(a) gene.
Mentioned in 2 videos
Videos Mentioning Antisense oligonucleotides
#07 – Deep Dive: Lp(a) — what every doctor, and the 10-20% of the population at risk, needs to know
Peter Attia MD
A class of drugs designed to lower Lp(a) by disrupting the synthesis of Apo(a) in the liver; showing high efficacy in clinical trials.
210 - Lp(a) and its impact on heart disease | Benoît Arsenault, Ph.D.& Peter Attia, M.D.
Peter Attia MD
A very exciting new class of drugs currently in development, designed to specifically lower Lp(a) levels by targeting the Lp(a) gene.